Akademisyen
ÖMER DENİZHAN TATAR
ARAŞTIRMA GÖREVLİSİ
NECMETTİN ERBAKAN ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Endokrinoloji ve Metabolizma Hastalıkları (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 28
- Proje 0
- Kitap 1
- Bildiri 8
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
8
Q2
8
Q3
3
Q4
5
WoS (JCR)
Q1
11
Q2
5
Q3
2
Q4
1
TR Index
8
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
1
Ort. yüzdelik
55.8%
Üst %1 payı
0.0%
Üst %10 payı
6.2%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Already a specialist, still a trainee: recognising dual professional identity in subspecialty fellowship YÖKSİS SJR Q2 JCR Q1 OpenAlex 77.3%
- 2026 Baseline body mass index and early functional recovery after first recorded advanced therapy in rheumatoid arthritis: a real-world cohort study YÖKSİS SJR Q2 JCR Q2 OpenAlex 54.6%
- 2026 Promising but not yet definitive: Interpreting prolactin-adjusted inferior petrosal sinus sampling in adrenocorticotropic hormone-dependent Cushing syndrome YÖKSİS SJR Q1 JCR Q1 OpenAlex 60.3%
- 2026 Non-invasive markers refine suspicion but do not by themselves establish etiology in ACTH-dependent Cushing syndrome YÖKSİS SJR Q2 JCR Q2 OpenAlex 73.8%
- 2026 Interpreting salivary cortisol thresholds in ectopic ACTH syndrome YÖKSİS SJR Q2 JCR Q2 OpenAlex 66.7%
- 2025 A Promising Prognostic Indicator for Pleural Mesothelioma: Pan-Immuno-Inflammation Value YÖKSİS SJR Q2 JCR Q1 OpenAlex 22.9%
- 2025 Hourly 4-minute walking breaks from sitting following aerobic exercise reduce postprandial non-HDL cholesterol in healthy young adults - A randomized crossover trial. YÖKSİS SJR Q1 JCR Q1 OpenAlex 77.7%
- 2025 Comparative Analysis of Prognostic Potential of Pretreatment Blood-Based Biomarkers in Metastatic Bladder Cancer: Modified Glasgow Prognostic Score YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %10 OpenAlex 93.3%
- 2025 Prognostic value of the StAN score in elderly small cell lung cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex 16.8%
- 2025 The lactate dehydrogenase-to-albumin ratio is a prognostic biomarker in extensive-stage small-cell lung cancer YÖKSİS TR Index OpenAlex 26.8%
- 2025 Adjuvant Gemcitabine-Cisplatin Combination for Biliary Tract Cancer: A Real Life Experience YÖKSİS TR Index OpenAlex 28.2%
- 2024 KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer YÖKSİS SJR Q3 JCR Q3 OpenAlex 15.7%
- 2024 Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer YÖKSİS SJR Q2 JCR Q2 OpenAlex 62.0%
- 2024 Sirolimus experience in adult patients with vascular malformations YÖKSİS SJR Q2 JCR Q4 OpenAlex 70.3%
- 2023 Role of the prognostic nutritional index in the treatment prediction of stage II colon cancer YÖKSİS
- 2023 Do statins enhance the antitumor effect of trastuzumab emtansine (T-DM1)?: Real-life cohort YÖKSİS SJR Q3 JCR Q2 OpenAlex 56.7%
- 2023 KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer YÖKSİS SJR Q3 JCR Q3 OpenAlex 89.8%
- 2022 AB0277 DYSLIPIDEMIA TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS USING bDMARDs IS BETTER THAN PsA, BUT THERE IS STILL A WAY TO GO YÖKSİS SJR Q1 JCR Q1
- 2022 AB0275 THE FREQUENCY, PREVALENCE OF CORONARY ARTERY DISEASE AND PRE-MATURE CAD IN PsA AND RA PATIENTS YÖKSİS SJR Q1 JCR Q1
- 2022 AB0278 IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING bDMARDs, THE CHARLSON COMORBIDITY INDEX IS MORE PRONOUNCED THAN PSORIATIC ARTHRITIS YÖKSİS SJR Q1 JCR Q1